ZX-29

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameZX-29
Drug Alias NameZX-29
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActivin receptor-like kinase 1 inhibitors
TargetsActivin receptor-like kinase 1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesShenyang Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A